BioCryst Pharmaceuticals (STU:BO1) Days Payable : 181.31 (As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is BioCryst Pharmaceuticals Days Payable?

BioCryst Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2024 was €11.6 Mil. BioCryst Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2024 was €5.9 Mil. Hence, BioCryst Pharmaceuticals's Days Payable for the three months ended in Dec. 2024 was 181.31.

The historical rank and industry rank for BioCryst Pharmaceuticals's Days Payable or its related term are showing as below:

STU:BO1' s Days Payable Range Over the Past 10 Years
Min: 384.24 Med: 1167.88 Max: 5465.7
Current: 384.24

During the past 13 years, BioCryst Pharmaceuticals's highest Days Payable was 5465.70. The lowest was 384.24. And the median was 1167.88.

STU:BO1's Days Payable is ranked better than
92.62% of 949 companies
in the Drug Manufacturers industry
Industry Median: 85.82 vs STU:BO1: 384.24

BioCryst Pharmaceuticals's Days Payable declined from Dec. 2023 (883.32) to Dec. 2024 (181.31). It may suggest that BioCryst Pharmaceuticals accelerated paying its suppliers.

BioCryst Pharmaceuticals Days Payable Historical Data

The historical data trend for BioCryst Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCryst Pharmaceuticals Days Payable Chart

BioCryst Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

3,707.12

1,135.43

1,118.81

1,396.76

463.47

BioCryst Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															883.32	1,072.63	515.48	303.96	181.31

Competitive Comparison of BioCryst Pharmaceuticals's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, BioCryst Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioCryst Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioCryst Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where BioCryst Pharmaceuticals's Days Payable falls into.

BioCryst Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BioCryst Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (19.159	+	11.12)	/	2 )	/	11.923	*	365
=	15.1395					/	11.923	*	365
=	463.47

BioCryst Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (12.147	+	11.12)	/	2 )	/	5.855	*	365 / 4
=	11.6335					/	5.855	*	365 / 4
=	181.31

BioCryst Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of BioCryst Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCryst Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioCryst Pharmaceuticals Inc (STU:BO1) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BCRX:USA

Address

4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703

Website

https://www.biocryst.com

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

BioCryst Pharmaceuticals Headlines

No Headlines